Literature DB >> 24652507

[Tarragona strategy--appropriate antibiotic therapy in the ICU].

L Engelmann1, D V Schmitt.   

Abstract

BACKGROUND: Appropriate antibiotic initial therapy remarkably decreases the mortality of patients with infections in the ICU. The establishment of an appropriate initial therapy follows empirical aspects. This practice was first done for the treatment of nosocomial pneumonia. Since that time the practice became known as Tarragona strategy.
RESULTS: The basic elements of the strategy are based on the initial antibiotic treatment of patients with infections in the ICU in general and include the following: view the patient and his/her medical history, consider the microbiologic environment, in which the patient became ill, test for possible causative microorganisms and initiate high-dose antibiotics immediately, evaluate pharmacokinetic/pharmacodynamic aspects influenced by the pathophysiologic processes in the critically ill patient, the specifics of the microorganisms, the peculiarity of the antibiotics in the patient and due to therapeutic procedures, and tailor the initial broad spectrum therapy as necessary according to the microbiological results.
CONCLUSION: This procedure is safe, reduces mortality, limits the development of resistance, and is economic.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24652507     DOI: 10.1007/s00063-013-0310-7

Source DB:  PubMed          Journal:  Med Klin Intensivmed Notfmed        ISSN: 2193-6218            Impact factor:   0.840


  29 in total

Review 1.  Principles of antibacterial dosing in continuous renal replacement therapy.

Authors:  Gordon Choi; Charles D Gomersall; Qi Tian; Gavin M Joynt; Alexander M M Y Li; Jeffrey Lipman
Journal:  Blood Purif       Date:  2010-10-06       Impact factor: 2.614

Review 2.  Appropriate use of antimicrobial agents: challenges and strategies for improvement.

Authors:  Michael S Niederman
Journal:  Crit Care Med       Date:  2003-02       Impact factor: 7.598

Review 3.  Clinical implications of antibiotic pharmacokinetic principles in the critically ill.

Authors:  Andrew A Udy; Jason A Roberts; Jeffrey Lipman
Journal:  Intensive Care Med       Date:  2013-09-18       Impact factor: 17.440

4.  Delaying the empiric treatment of candida bloodstream infection until positive blood culture results are obtained: a potential risk factor for hospital mortality.

Authors:  Matthew Morrell; Victoria J Fraser; Marin H Kollef
Journal:  Antimicrob Agents Chemother       Date:  2005-09       Impact factor: 5.191

5.  Effect of empirical treatment with moxifloxacin and meropenem vs meropenem on sepsis-related organ dysfunction in patients with severe sepsis: a randomized trial.

Authors:  Frank M Brunkhorst; Michael Oppert; Gernot Marx; Frank Bloos; Katrin Ludewig; Christian Putensen; Axel Nierhaus; Ulrich Jaschinski; Andreas Meier-Hellmann; Andreas Weyland; Matthias Gründling; Onnen Moerer; Reimer Riessen; Armin Seibel; Maximilian Ragaller; Markus W Büchler; Stefan John; Friedhelm Bach; Claudia Spies; Lorenz Reill; Harald Fritz; Michael Kiehntopf; Evelyn Kuhnt; Holger Bogatsch; Christoph Engel; Markus Loeffler; Marin H Kollef; Konrad Reinhart; Tobias Welte
Journal:  JAMA       Date:  2012-06-13       Impact factor: 56.272

6.  Predictors of mortality in bloodstream infections caused by Klebsiella pneumoniae carbapenemase-producing K. pneumoniae: importance of combination therapy.

Authors:  Mario Tumbarello; Pierluigi Viale; Claudio Viscoli; Enrico Maria Trecarichi; Fabio Tumietto; Anna Marchese; Teresa Spanu; Simone Ambretti; Francesca Ginocchio; Francesco Cristini; Angela Raffaella Losito; Sara Tedeschi; Roberto Cauda; Matteo Bassetti
Journal:  Clin Infect Dis       Date:  2012-07-02       Impact factor: 9.079

7.  De-escalation therapy in ventilator-associated pneumonia.

Authors:  Jordi Rello; Loreto Vidaur; Alberto Sandiumenge; Alejandro Rodríguez; Belen Gualis; Carmen Boque; Emili Diaz
Journal:  Crit Care Med       Date:  2004-11       Impact factor: 7.598

8.  Community-acquired bloodstream infection in critically ill adult patients: impact of shock and inappropriate antibiotic therapy on survival.

Authors:  Jordi Vallés; Jordi Rello; Ana Ochagavía; José Garnacho; Miguel Angel Alcalá
Journal:  Chest       Date:  2003-05       Impact factor: 9.410

9.  High-dose, extended-interval colistin administration in critically ill patients: is this the right dosing strategy? A preliminary study.

Authors:  Lidia Dalfino; Filomena Puntillo; Adriana Mosca; Rosa Monno; Maria Luigia Spada; Sara Coppolecchia; Giuseppe Miragliotta; Francesco Bruno; Nicola Brienza
Journal:  Clin Infect Dis       Date:  2012-03-15       Impact factor: 9.079

10.  Effect of blood protein concentrations on drug-dosing regimes: practical guidance.

Authors:  Konstantin G Gurevich
Journal:  Theor Biol Med Model       Date:  2013-03-18       Impact factor: 2.432

View more
  2 in total

1.  [32/f-Hip and back pain : Preparation for the medical specialist examination: part 146].

Authors:  M Angstwurm
Journal:  Internist (Berl)       Date:  2022-02-17       Impact factor: 0.743

2.  The association of the anesthesiologist's academic and educational status with self-confidence, self-rated knowledge and objective knowledge in rational antibiotic application.

Authors:  Frederick Schneider; Christian M Schulz; Matthias May; Gerhard Schneider; Christian Ernst; Matthias Jacob; Kai Zacharowski; Thomas Hachenberg; Maren Schmidt; Moritz Kretzschmar; Bernhard Graf; Martin G Kees; Michael Pawlik; Michael Sander; Christian Koch; Michael Zoller; Markus Heim
Journal:  BMC Res Notes       Date:  2020-03-18
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.